(688298)"Zhejiang Orient Gene Biotech Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 688298 · · 13 pages · Chinese
Summary by 6ix AI
The company assures that the report's content is accurate and complete, and it has not been audited. Additionally, the report highlights ongoing litigation that may impact future financial results, although current operations remain stable.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Orient Gene Biotech Co., Ltd. on 6ix
Earlier from Zhejiang Orient Gene Biotech
- Announcement on Voluntary Disclosure of Obtaining a Medical Device Registration Certificate
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate
- Semi-annual Report for 2026
- Announcement on SSE’s Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
- Announcement on Election of Employee Representative Directors for the 4th Board of Directors
Follow Zhejiang Orient Gene Biotech into a list and get an email when it puts out news.
Follow Zhejiang Orient Gene Biotech